Related Experiment Video
Updated: Jun 26, 2026

A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders
Published on: June 9, 2014
Osteoporosis, genetics and hormones
R Rizzoli1, J P Bonjour, S L Ferrari
1Division of Bone Diseases, WHO Collaborating Center for Osteoporosis and Bone Diseases, Department of Internal Medicine, University Hospital, 1211 Geneva 14, Switzerland. rizzoli@cmu.unige.ch
Osteoporosis is a bone disease causing low bone mass and deterioration. Bone loss accelerates after menopause, significantly altering bone structure and increasing fracture risk.
Area of Science:
- Bone biology
- Skeletal physiology
- Osteoporosis research
Background:
- Osteoporosis is a systemic skeletal disease defined by low bone mass and microarchitectural deterioration.
- Peak bone mass achieved during growth and subsequent age-related bone loss determine bone mass at any given age.
- Bone loss accelerates significantly after menopause, impacting skeletal integrity.
Purpose of the Study:
- To elucidate the mechanisms of bone mass acquisition and loss.
- To understand the differential changes in bone mass and microarchitecture across the lifespan.
- To highlight the impact of menopause on skeletal deterioration.
Main Methods:
- Review of established literature on bone physiology and osteoporosis.
- Analysis of factors influencing peak bone mass and age-related bone loss.
- Examination of microarchitectural changes in bone tissue.
Main Results:
- Bone mass is a result of peak bone mass minus age-related bone loss.
- Bone mass gain during puberty primarily involves increased bone size.
- Postmenopausal bone loss involves thinning of cortices and trabeculae, leading to microarchitectural deterioration.
Conclusions:
- Osteoporosis is characterized by reduced bone mass and compromised bone microarchitecture.
- Menopause significantly accelerates bone loss, altering skeletal structure.
- Understanding these processes is crucial for managing osteoporosis and preventing fractures.
Related Concept Videos
Bone Remodeling
Osteoclasts in Bone Remodeling
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Target Cell Response to Hormones
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
Major Hormones and Their Functions
Oxytocin, produced in the hypothalamus and released by the pituitary gland, plays a role in social bonding, childbirth, and lactation.

